health · education · HHS-NIH11
Digital Health Technology Derived Biomarkers and Outcome Assessments for Remote Monitoring and Endpoint Development (UG3/UH3 - Clinical Trial Optional)
National Institutes of Health · PAR-25-170
Deadline
June 22, 2026
GRANTQUICK SUMMARYPlain-English Overview
Digital Health Technology Derived Biomarkers and Outcome Assessments for Remote Monitoring and Endpoint Development (UG3/UH3 - Clinical Trial Optional). National Institutes of Health. The purpose of this proposed Notice of Funding Announcement (NOFO) is to support development of biomarkers or clinical outcomes derived from digital health technology (DHT) for use in clinical trials for remote monitoring as primary or secondary endpoints. To improve clinical impact, increase... Funding amounts not specified.
Who Should Apply
Nonprofits (non-501c3), Other Native American Tribal Organizations, Nonprofits (501c3), Small businesses, For-profit organizations (+10 more)
Who Should NOT Apply
Organizations not matching the eligible applicant types listed above
Key Requirements (Plain English)
- •Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Isl...
- •Deadline: 2026-06-22
💡 GrantQuick Tip
Focus your proposal on clear outcomes, alignment with agency priorities, and demonstrate organizational capacity.
Competitiveness: Moderate to high — federal grants are always competitive
What This Grant Funds
Attachments
Who Can Apply
Eligible Applicant Types
Funding Details
- Cost Sharing Required?
- No
- Funding Instrument
- cooperative_agreement
Key Dates
Agency Contact
NIH Grants Information grantsinfo@nih.gov
grantsinfo@nih.govReady to apply?
View the full NOFO and submit your application on Grants.gov